SCHEMBL30815035

SCHEMBL30815035

N#Cc1nccc(NC2CC3(CCNCC3)C2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 2/20 0.58
▸ HRH3 Q9Y5N1 4/20 0.43
▸ FLT3 P36888 3/20 0.38
▸ PIM1 P11309 2/20 0.38
▸ PIM3 Q86V86 2/20 0.38
▸ PIM2 Q9P1W9 2/20 0.38
▸ ROCK2 O75116 1/20 0.36
▸ HRH4 Q9H3N8 2/20 0.36
▸ PRKD1 Q15139 1/20 0.35
▸ PRKD2 Q9BZL6 1/20 0.35
▸ KDM1A O60341 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ IRAK1 P51617 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ CTSL P07711 1/20 0.33
▸ CTSB P07858 1/20 0.33
▸ CTSS P25774 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27226207 1.00 CTSK (0.58) CTSKHRH3FLT3PIM1PIM3
SCHEMBL30815456 0.88 CTSK (0.62) CTSKHRH3FLT3ROCK2HRH4
SCHEMBL27227105 0.88 CTSK (0.62) CTSKHRH3FLT3ROCK2HRH4
SCHEMBL27311124 0.82 CTSK (0.55) CTSKHRH3ROCK2CYP1A2CYP2C19
SCHEMBL27226580 0.82 CTSK (0.74) CTSKHRH3HRH4PRKD1PRKD2
SCHEMBL30815053 0.82 CTSK (0.74) CTSKHRH3HRH4PRKD1PRKD2
SCHEMBL27225969 0.80 CTSK (0.65) CTSKHRH3HRH4PRKD1PRKD2
SCHEMBL27226113 0.79 CTSK (0.68) CTSKHRH3FLT3HRH4PRKD1
SCHEMBL27226520 0.78 CTSK (0.39) CTSKROCK2KDM1AMAOBCTSL
SCHEMBL23830884 0.77 CTSK (0.66) CTSKHRH3FLT3HRH4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 — — EP disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback